GlassScriptPhysician profile
Tamara Mishkel
NPI 1760263230
$1,235.02
in general payments reported to CMS, 2019-2025
18 companies · $1,035 in 2025
The $1,035 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $200 · 2025: $1,035.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,235.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $231.68 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $210.33 | 2025 | Camzyos |
| Cleerly, INC. | $148.59 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Atricure, INC. | $111.87 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $87.87 | 2025 | Jardiance |
| Boston Scientific Corporation | $74.35 | 2025 | Watchman Flx |
| Novo Nordisk INC | $66.14 | 2024-2025 | Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $64.50 | 2024-2025 | Farxiga |
| Abbott Laboratories | $51.48 | 2025 | Diamondback Peripheral, Amplatzer Amulet |
| Amgen INC. | $41.67 | 2024-2025 | Repatha, Repatha |
| Lilly USA, LLC | $26.07 | 2025 | Zepbound, Mounjaro |
| Bridgebio Pharma, INC. | $21.90 | 2025 | Attruby |
| Merck Sharp & Dohme LLC | $19.97 | 2025 | Verquvo |
| Tactile Systems Technology INC | $17.25 | 2025 | Nimbl, Flexitouch Plus |
| Alnylam Pharmaceuticals INC. | $16.08 | 2025 | Onpattro |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $15.86 | 2025 | Micra |
| Esperion Therapeutics, INC. | $14.95 | 2025 | Nexletol |
| Inspire Medical Systems, INC. | $14.46 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamara Mishkel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.